Incannex Healthcare Inc.
IXHL
$3.17
-$0.14-4.23%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -16.90% | 48.30% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 1.69% | -19.54% | |||
| Operating Income | -1.69% | 19.54% | |||
| Income Before Tax | -1.78% | 79.73% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -1.78% | 79.73% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -1.78% | 79.73% | |||
| EBIT | -1.69% | 19.54% | |||
| EBITDA | -1.81% | 20.01% | |||
| EPS Basic | 9.62% | 94.57% | |||
| Normalized Basic EPS | 9.61% | 94.49% | |||
| EPS Diluted | 9.62% | 94.57% | |||
| Normalized Diluted EPS | 9.61% | 94.49% | |||
| Average Basic Shares Outstanding | 12.62% | 273.42% | |||
| Average Diluted Shares Outstanding | 12.62% | 273.42% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||